Publication | Open Access

Comparison of Effects of Rosuvastatin (10 mg) Versus Atorvastatin (40 mg) on Rho Kinase Activity in Caucasian Men With a Previous Atherosclerotic Event

Vascular DiseaseCardiovascular DiseasePharmacologyHyperlipidemiaVascular BiologyRho Kinase ActivityVersus AtorvastatinMedicineAtherosclerosisDyslipidemiaCaucasian MenOxidative Stress